Buprenorphine Patch, Extended Release
Product Images NDC 3215-1523

26 FDA label images from Aveva Drug Delivery Systems Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 3215-1523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aveva Drug Delivery Systems Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Table1)

FDA Label Image

Structure (Structure)

FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig2 (Fig2)

FDA Label Image

Fig3 (Fig3)

FDA Label Image

Fig4 (Fig4)

FDA Label Image

Image Description (Figa)

FDA Label Image

Image Description (Figb)

FDA Label Image

Image Description (Figc)

FDA Label Image

Image Description (Figd)

FDA Label Image

Image Description (Fige)

FDA Label Image

Image Description (Figf)

FDA Label Image

Image Description (Figg)

FDA Label Image

Image Description (Figh)

FDA Label Image

Image Description (Figi)

FDA Label Image

Image Description (Figj)

FDA Label Image

Image Description (Figk)

FDA Label Image

Image Description (Figl)

FDA Label Image

Image Description (Figm)

FDA Label Image

Image Description (Fign)

FDA Label Image

Image Description (Figo)

FDA Label Image

Carton-5mcg (Image01)

Carton-5mcg (Image01)
Packaging label for Buprenorphine Transdermal System 5 mcg/hour patch by Aveva Drug Delivery Systems Inc. The carton indicates a package containing 4 transdermal systems and 4 disposal units. Label includes dosage strength, instructions for systemic delivery over seven days, and disposal information.*
FDA Label Image

Carton-7.5mcg (Image002)

Carton-7.5mcg (Image002)
Packaging label for Buprenorphine Transdermal System 7.5 mcg/hour extended-release patch by Aveva Drug Delivery Systems Inc. The carton includes 4 transdermal systems and 4 disposal units. It is for use in opioid-experienced patients only and provides system delivery of 7.5 mcg per hour for seven days. The label includes warnings and directions for safe use.*
FDA Label Image

Carton-10mcg (Image003)

Carton-10mcg (Image003)
Box packaging label for Buprenorphine Transdermal System 10 mcg/hour patch by Aveva Drug Delivery Systems Inc. The label states it contains 4 transdermal systems in one package including 4 disposal units. It highlights the systemic delivery rate and cautions for opioid-experienced patients. The packaging includes space for affixing a pharmacy label.*
FDA Label Image

Carton-15mcg (Image04)

Carton-15mcg (Image04)
The image shows the carton packaging for Buprenorphine Transdermal System 15 mcg/hour, a patch extended release dosage form for transdermal use. The label indicates the package contains 4 transdermal systems and 4 disposal units. It is labeled by Aveva Drug Delivery Systems Inc. and includes warnings about proper use and disposal.*
FDA Label Image

Carton-20mcg (Image05)

Carton-20mcg (Image05)
Buprenorphine Transdermal System 20 mcg/hour extended-release patch packaging label. The label indicates systemic delivery of 20 mcg per hour of buprenorphine via transdermal patch with a package containing 4 transdermal systems and 4 disposal units. It includes warnings about proper use and disposal, the labeler Aveva Drug Delivery Systems Inc., and space for affixing the pharmacy label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.